These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3181799)

  • 21. Risks of blood transfusion and their prevention.
    Sandler SG; Yu H; Rassai N
    Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transfusion associated graft versus host disease (TA-GVHD)].
    Takahashi K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):605-8. PubMed ID: 9851229
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusion-associated graft-versus-host disease in a newborn.
    Ozdoğan T; Metin F; Doğu A; Timur C; Yildiz E
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):271-2. PubMed ID: 17450462
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progress in the field of hematology in the last 100 years: Clinical guidelines for irradiation of blood to prevent graft-versus-host disease following blood transfusion].
    Ito K
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2161-8. PubMed ID: 12187692
    [No Abstract]   [Full Text] [Related]  

  • 25. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
    Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD
    J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Posttransfusion GVHD].
    Ito K
    Rinsho Ketsueki; 1996 Jun; 37(6):488-91. PubMed ID: 8752979
    [No Abstract]   [Full Text] [Related]  

  • 29. Irradiated blood components.
    Mathai J
    Indian J Med Res; 2005 Nov; 122(5):371-3. PubMed ID: 16456248
    [No Abstract]   [Full Text] [Related]  

  • 30. [Graft-versus-host reaction as a complication of blood transfusion].
    Fiala J
    Vnitr Lek; 1984 Sep; 30(9):908-13. PubMed ID: 6390940
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

  • 32. Graft-versus-host disease: introduction and prospect.
    Ohto H; Suzuki H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of TAGVHD warnings in patients receiving purine analogue chemotherapy.
    Cutler FJ; Niciu C; Murphy JA; Soutar RL
    Transfus Med; 2008 Apr; 18(2):137-8. PubMed ID: 18399848
    [No Abstract]   [Full Text] [Related]  

  • 34. [Posttransfusion graft vs host disease].
    Muñoz MC; Hernández M; Rifón J; Panizo C; Rodríguez M
    Sangre (Barc); 1998 Feb; 43(1):55-8. PubMed ID: 9580428
    [No Abstract]   [Full Text] [Related]  

  • 35. Common reactions to transfusions.
    Gloe D
    Heart Lung; 1991 Sep; 20(5 Pt 1):506-12. PubMed ID: 1894531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special issues in transfusion medicine.
    Harrison CR; Sawyer PR
    Clin Lab Med; 1992 Dec; 12(4):743-57. PubMed ID: 1286562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of posttransfusion graft-versus-host disease by leukocyte depletion filter].
    Handa M
    Nihon Rinsho; 1997 Sep; 55(9):2282-9. PubMed ID: 9301291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and evaluation of risk in the graft versus host reaction following transfusion].
    von Fliedner VE; Grob JP; Barrelet L
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1521-3. PubMed ID: 6635642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaphylactic transfusion reactions associated with anti-IgA antibody.
    Schmidt AP; Taswell HF; Gleich GJ
    N Engl J Med; 1969 Jan; 280(4):188-93. PubMed ID: 4177970
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse effects of transfusions caused by leukocytes.
    Raife TJ
    J Intraven Nurs; 1997; 20(5):238-44. PubMed ID: 9369624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.